Research is especially important during Less Survivable Cancers Week because these cancers face unique and urgent challenges that directly affect survival outcomes. These cancers include liver and pancreatic cancers.
Research drives earlier diagnosis. For many less survivable cancers, symptoms appear only once the disease is advanced. Research helps develop better screening tools, biomarkers, and imaging techniques so cancers can be detected sooner, when treatment is more likely to work.
Research leads to better treatments. Patients with less survivable cancers often have fewer effective therapies and limited clinical trial options. Investment in research fuels the development of targeted therapies, immunotherapies, and personalized medicine that can improve outcomes and quality of life.
Research gives hope. Every breakthrough, trial, and discovery represents hope for patients and families facing the toughest diagnoses. Progress in survival rates is only possible through sustained research funding and scientific innovation.
During Less Survivable Cancers Week, we highlight that increasing research isn’t just about science—it’s about saving lives, extending time, and creating a future where no cancer is overlooked.
